Zoetis
Trade Zoetis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ZTS
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.
ZTS Key Statistics
Stock Snapshot
With a market cap of 53.44B, Zoetis(ZTS) trades at $126.76. The stock has a price-to-earnings ratio of 21.03 and currently yields dividends of 1.6%.
On 2026-02-16, Zoetis(ZTS) stock moved within a range of $125.65 to $130.64. With shares now at $126.76, the stock is trading +0.9% above its intraday low and -3.0% below the session's peak.
Trading activity shows a volume of 4.48M, compared to an average daily volume of 5.1M.
Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $177.00 and a low of $115.25.
Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $177.00 and a low of $115.25.
ZTS News
In February 2026, Zoetis Inc. reported fourth-quarter 2025 sales of US$2,387 million and net income of US$603 million, with full-year 2025 sales of US$9.47 bill...
Zoetis (ZTS) has disclosed a new risk, in the Debt & Financing category. Zoetis faces liquidity risk if the conditional conversion feature on its convertible s...
Regulators are increasing scrutiny of Zoetis' monoclonal antibody pain therapies, including Librela, leading to updated FDA safety warnings. At the same time,...
Analyst ratings
62%
of 21 ratingsMore ZTS News
BofA raised the firm’s price target on Zoetis (ZTS) to $140 from $135 and keeps a Neutral rating on the shares. Q4 was relatively in-line with expectations, as...
Animal health firm Zoetis Inc. (NYSE:ZTS) on Thursday reported a fourth-quarter 2025 adjusted earnings per share of $1.48. The company beat the consensus of $1....
Despite posting better-than-expected financials for Q4 2025, Zoetis (ZTS) traded lower on Thursday after the animal health company projected a slowdown in its t...
(RTTNews) - Zoetis Inc. (ZTS), a manufacturer of animal health medicines, Thursday reported higher earnings and revenue for the fourth quarter compared to the s...
Reports Q4 revenue $2.39B, consensus $2.36B. “Zoetis (ZTS) delivered solid results in 2025, demonstrating the strength and resilience of our portfolio across sp...
Zoetis Inc. (NYSE:ZTS) will release earnings for its fourth quarter before the opening bell on Thursday, Feb. 12. Analysts expect the Parsippany, New Jersey-ba...
Advertisement Dividend affirmation and earnings catalyst Zoetis (ZTS) has reaffirmed its shareholder return plans with a second quarter 2026 dividend of $0.53...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.